Article Details

RSV: Safety, Efficacy and Tolerability of Palivizumab | DHPS - Dove Medical Press

Retrieved on: 2023-09-11 03:53:04

Tags for this article:

Click the tags to see associated articles and topics

RSV: Safety, Efficacy and Tolerability of Palivizumab | DHPS - Dove Medical Press. View article details on hiswai:

Excerpt

Suptavumab is another human monoclonal antibody developed for RSV-disease prophylaxis. However, in August 2017 Regeneron Pharmaceuticals discontinued ...

Article found on: www.dovepress.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up